EP2710031
IMPROVED PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
17.5.2012EP published:
13.9.2017EP application number:
12785861.1
EPO information:
European Patent Register
Max expiry date:
16.5.2032
Title:
IMPROVED PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE
Timeline
Today
17.5.2012EP application
13.9.2017EP Publication
Owner
Name:
Mederis Diabetes, LLCAddress:
725 Lynwood Drive, 92024, Encinitas, CA, US
Inventor
Name:
NESTOR, John, J.Address:
EncinitasCA, US
Priority
Number:
201161487640 PDate:
18.5.2011Country:
US
Number:
201161543716 PDate:
5.10.2011Country:
US
Classification
Categories:
A61K 47/60, C07K 14/605, A61K 38/26, C07H 15/04, A61P 3/10